| Gene symbol | GPC3 | Synonyms | DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq26.2 | dbXrefs | |
| Description | glypican 3 | ||||
| GTO ID | GTC2350 |
| Trial ID | NCT04377932 |
| Disease | Wilms' Tumor | Liver Cancer | Rhabdomyosarcoma | Yolk Sac Tumor | Liposarcoma |
| Altered gene | GPC3 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | AGAR T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors |
| Year | 2020 |
| Country | United States |
| Company sponsor | Baylor College of Medicine |
| Other ID(s) | H-47757 AGAR |
| Cohort 1 | |||||||||
|
|||||||||